Besides, IL20RA expression is also positively correlated with the clinical outcome of patients in patients of bladder carcinoma, uterine corpus endometrial carcinoma, rectum adenocarcinoma, and gastric cancer (Figure 2—figure supplement 1). This evidence concerns the gene IL20RA and uterine corpus endometrial carcinoma.